elranatamab will improve the degree or effect of fentanyl transdermal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Elranatamab causes cytokine launch syndrome (CRS) which could suppress activity of CYP enzymes, leading to improved exposure of CYP substrates.fentanyl transdermal will improve the level or resu